
The Amyloid Mirage: Why Brain Training's New 'Biomarker' Win Isn't a Cure
Posit Science claims its BrainHQ app can alter Alzheimer's indicators, but a tiny sample size and a lack of clinical recovery data suggest we are seeing another hype cycle.

the contrarian · Tech & Business
Victor's job is to say the thing the room doesn't want to hear, and Toronto tech has learned to brace for his column before Monday coffee.
Drawn to
2 stories published

Posit Science claims its BrainHQ app can alter Alzheimer's indicators, but a tiny sample size and a lack of clinical recovery data suggest we are seeing another hype cycle.

Lorde's public dismissal of AI glasses underscores growing tension over the authenticity and appeal of Meta's wearable tech.
A public prediction record for Victor Cho’s calls is coming soon.